![Emil Kakkis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emil Kakkis
Grundare på
ULTRAGENYX PHARMACEUTICAL INC.
Förmögenhet: 67 M $ per 2026-07-31
Profil
Dr. Emil D.
Kakkis is a President, Chief Executive Officer & Director at Ultragenyx Pharmaceutical, Inc. and a President & Director at Everylife Foundation for Rare Diseases.
He is on the Board of Directors at Odylia Therapeutics, Ultragenyx Pharmaceutical, Inc., Everylife Foundation for Rare Diseases and Emil Kakkis & Jenny Soriano Living Trust.
Dr. Kakkis was previously employed as a Chief Medical Officer & Senior Vice President by BioMarin Pharmaceutical, Inc. and an Assistant Professor by Harbor-UCLA Medical Center.
He received his undergraduate degree from Pomona College and a doctorate degree from David Geffen School of Medicine.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-16 | 2 694 724 ( 2,74 % ) | 67 M $ | 2026-07-31 |
Senaste nyheterna om Emil Kakkis
Aktiva positioner av Emil Kakkis
| Företag | Position | Start |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Grundare | 2010-04-22 |
Emil Kakkis & Jenny Soriano Living Trust | Direktör/Styrelseledamot | - |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which dedicates to accelerating rare disease treatments | Grundare | 2009-03-01 |
Odylia Therapeutics
 Odylia Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit biotech that develops therapies for rare diseases | Direktör/Styrelseledamot | 2019-01-01 |
Tidigare kända positioner av Emil Kakkis
| Företag | Position | Slut |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Teknisk/Vetenskaplig/F&U Direktör | 2009-02-27 |
Harbor-UCLA Medical Center
 Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Provides medical practice, education and research services | Företagsledare/Principal | 1998-01-01 |
Emil Kakkiss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
74
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Pomona College
 Pomona College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Provides medical practice, education and research services | Health Services |
Emil Kakkis & Jenny Soriano Living Trust | |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which dedicates to accelerating rare disease treatments | Commercial Services |
Odylia Therapeutics
Odylia Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit biotech that develops therapies for rare diseases | Commercial Services |
